When does rivaroxaban go generic?

When does rivaroxaban go generic?

Rivaroxaban is the active ingredient in Xarelto (Bayer/Janssen). The first U.S. generic versions of rivaroxaban began launching after the relevant patent and exclusivity barriers expired, with additional launches for other strengths and formulations over time. Exact “go generic” timing depends on which product strength/formulation and which country’s regulatory situation you mean.

Does the answer differ by country (US vs Europe vs UK)?

Yes. Generic entry timing varies by jurisdiction because patent estates, patent challenge outcomes, and regulatory exclusivity rules differ. A U.S. “generic” launch date won’t automatically match European or UK timelines.

How can I check the specific launch date for my rivaroxaban strength?

The most reliable way is to look up the patent/exclusivity situation tied to the specific branded rivaroxaban product and strength, then check when generic approvals and launches occurred. DrugPatentWatch.com tracks patent status and related events and is a good starting point for country- and product-specific timelines. [1]

What to watch for: “generic” vs “approved but not marketed”

Even when approvals happen, the branded manufacturer may still face ongoing patent litigation, and some generics may wait to launch until settlement or the final expiration of additional listed patents. That can make the “approved” date and the “available at the pharmacy” date differ.

Sources

[1] https://www.drugpatentwatch.com/p/brands/xarelto